Skip to main content

Animations

MJFF Publications

5341 - 5350 of 6458 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    OPEN
    Title: Stress-inducible phosphoprotein 1 (HOP/STI1/STIP1) regulates the accumulation and toxicity of α-synuclein in vivo
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00401-022-02491-8
    Citation Count: 31
  • Summary Details
    OPEN
    Title: Bacterial Butyrate in Parkinson's Disease Is Linked to Epigenetic Changes and Depressive Symptoms
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29128
    Citation Count: 115
  • Summary Details
    OPEN
    Title: Spatial snapshots of amyloid precursor protein intramembrane processing via early endosome proteomics
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-022-33881-x
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Reliability of Automatic Computer Vision-Based Assessment of Orofacial Kinematics for Telehealth Applications
    Journal Name: Digital Biomarkers
    Publisher: S. Karger AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1159/000525698
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis
    Journal Name: Frontiers in Neurology
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fneur.2022.919778
    Citation Count: 13
  • Summary Details
    OPEN
    Title: A feed-forward pathway drives LRRK2 kinase membrane recruitment and activation
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.79771
    Citation Count: 66
  • Summary Details
    OPEN
    Title: Artificial intelligence-enabled detection and assessment of Parkinson’s disease using nocturnal breathing signals
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-022-01932-x
    Citation Count: 271
  • Summary Details
    OPEN
    Title: Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review
    Journal Name: Dystonia
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/dyst.2022.10359
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Using former carers’ expertise in peer support for carers of people with Parkinson’s Disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-022-00381-0
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Pericytes take up and degrade α-synuclein but succumb to apoptosis under cellular stress
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-022-20261-0
    Citation Count: 31
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.